Nanomedicine News

RSS
ADMEcell Enters into Exclusive Agreement with Leader in Nanomedicine

ADMEcell Enters into Exclusive Agreement with Leader in Nanomedicine

Arcxis Biotechnologies Announces Strategic Partnership and Technology Development Agreement with In-Q-Tel

CombiMatrix Receives Four Year Contract from NASA to Design and Test Microfluidic System

CombiMatrix Receives Four Year Contract from NASA to Design and Test Microfluidic System

Scientists Develop for First Time Nano Treatment that Transports 'Tumour Busting' Genes Selectively to Cancer Cells

Scientists Develop for First Time Nano Treatment that Transports 'Tumour Busting' Genes Selectively to Cancer Cells

Developing an Efficient Pathway for Safe and Effective Nanoengineered Medical Products

Developing an Efficient Pathway for Safe and Effective Nanoengineered Medical Products

Team Put in Place to Serve Future Requirements of Stem Cell Researchers

Intel Announces Winners of America's Oldest and Most Prestigious Pre-College Science Competition

Intel Announces Winners of America's Oldest and Most Prestigious Pre-College Science Competition

Project Focuses on All Aspects of Nanomedicine

Funding Allocated to Research and Development Targeting Early Diagnosis and Treatment of Disease

Twin Nanoparticle Showing Greater Success at Killing Breast Cancer While Minimizing Anti-Cancer Drug's Side Effects

Twin Nanoparticle Showing Greater Success at Killing Breast Cancer While Minimizing Anti-Cancer Drug's Side Effects

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.